1Van't Veer C, Golden NJ, Kalafatis M,et al. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor[J]. The Journal of biological chemistry, 1997, 2
2Dourakis SP,Tolis G. Sex hormonal preparations and the liver. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 1998, 3(1):7-16
3Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review[J].The American journal of gastroenterology, 2002,97(3):535-541
6Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis[J]. Gastroenterology, 1995,109(2):531-539.
7Vukovich T, Teufelsbauer H, Fritzer M. Hemostasis activation in patients with liver cirrhosis[J] .Thromb Res, 1995,77(3):271-278.
8Ferro D, Basili S, Lattuada A, et al. Systemic clotting activation by lowgrade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation[J]. ltal J Gastroenterol Hepatol, 1997,29 (5) :434-440.
9Violi F, Ferro D, Basili S, et al. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis[J]. Hepatology,1993,17(1) :78-83.
10Colueei M, Binetti BM, Branea MB, et al. Deficiency of thrembin aetivatable fibrinolysis inhibitor in cirrhosis Is associated with increase plasma fibrinolysis[ J]. Hepatology, 2003,38( 1 ) : 230-237.
8KRUSKAL RJ,SEITZ D,NOLAN CR,et al.Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease[J].Hepatology,1992,16:920.
9VIOLI F,FERRO D,BASILI S,et al.Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis[J].Thromb Res,1995,77(3):271.
